NCT06730347
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06730347
Title A Study of Lorigerlimab in Participants With Advanced Solid Tumors
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors MacroGenics
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | CAN

Facility Status City State Zip Country Details
UCLA RECRUITING Los Angeles California 90095 United States Details
Ochsner MD Anderson Cancer Center RECRUITING New Orleans Louisiana 70115 United States Details
START Midwest RECRUITING Grand Rapids Michigan 49546 United States Details
West Penn Allegheny Health RECRUITING Pittsburgh Pennsylvania 15224 United States Details
Mays Clinic RECRUITING Houston Texas 77030 United States Details
START San Antonio RECRUITING San Antonio Texas 78229 United States Details
Wisconsin Institute Medical Research- UW Cancer Connect RECRUITING Madison Wisconsin 53705 United States Details
Princess Margaret Cancer Center RECRUITING Toronto Ontario M5G 2M9 Canada Details
McGill University RECRUITING Montreal Quebec H4A3J1 Canada Details
National Cancer Center RECRUITING Goyang-si Gyeonggi-do 410-763 South Korea Details
Seoul National University Hospital Bundang Hospital RECRUITING Seongnam-si Gyeonnggi-Do 463-707 South Korea Details
Yonsei University Health System Severance Hospital RECRUITING Seoul 03722 South Korea Details
Gangnam Severance Hospital RECRUITING Seoul 06273 South Korea Details
Korea University Guro Hospital RECRUITING Seoul 08308 South Korea Details
Seoul National University Hospital RECRUITING Seoul 110-74 South Korea Details
Samsung Medical Center RECRUITING Seoul 135-710 South Korea Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field